Oncolys BioPharma, Inc. (4588) Income Statement

Last quarter (Q2 2025), Oncolys BioPharma, Inc.'s total revenue was ¥28.55M, a decrease of -9.04% from the same quarter last year. In Q2, Oncolys BioPharma, Inc.'s net income was ¥-501.58M. See Oncolys BioPharma, Inc.’s key income statements, including revenue, expenses, profit, and income.